Baillie Gifford acquired 1.22M Twist Bioscience shares worth $89.8M. That's 0.07% of their equity portfolio (127th largest holding). The investor owns 2.16% of the outstanding Twist Bioscience stock. The first Twist Bioscience trade was made in Q3 2022. Since then Baillie Gifford bought shares six more times and sold shares on eight occasions. The stake costed the investor $42.2M, netting the investor a gain of 113% so far.